These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 1850821

  • 1. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor.
    Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV.
    Nature; 1991 Apr 25; 350(6320):678-83. PubMed ID: 1850821
    [Abstract] [Full Text] [Related]

  • 2. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F, Klein R, Barbacid M.
    Princess Takamatsu Symp; 1991 Apr 25; 22():153-70. PubMed ID: 1844238
    [Abstract] [Full Text] [Related]

  • 3. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
    Colangelo AM, Fink DW, Rabin SJ, Mocchetti I.
    Glia; 1994 Oct 25; 12(2):117-27. PubMed ID: 7868185
    [Abstract] [Full Text] [Related]

  • 4. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.
    Cancer Res; 1995 May 15; 55(10):2212-9. PubMed ID: 7538048
    [Abstract] [Full Text] [Related]

  • 5. Terminal differentiation in neuroblastoma cells transfected with the NGF receptor gene when treated with NGF.
    Matsushima H, Bogenmann E.
    Prog Clin Biol Res; 1991 May 15; 366():227-33. PubMed ID: 1648742
    [No Abstract] [Full Text] [Related]

  • 6. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S.
    Cell Growth Differ; 1995 Jun 15; 6(6):727-36. PubMed ID: 7669728
    [Abstract] [Full Text] [Related]

  • 7. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A, Orlandi R, Mariani C, Miranda C, Borrello MG, Cattaneo A, Pagliardini S, Pierotti MA.
    Cell Growth Differ; 1993 Jul 15; 4(7):539-46. PubMed ID: 8398895
    [Abstract] [Full Text] [Related]

  • 8. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.
    Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF.
    Science; 1991 Apr 26; 252(5005):554-8. PubMed ID: 1850549
    [Abstract] [Full Text] [Related]

  • 9. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 10. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J, Vroegop SM, Buxser SE, Neet KE.
    J Neurosci Res; 1994 Mar 01; 37(4):433-44. PubMed ID: 7517456
    [Abstract] [Full Text] [Related]

  • 11. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor.
    Meakin SO, Suter U, Drinkwater CC, Welcher AA, Shooter EM.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2374-8. PubMed ID: 1312719
    [Abstract] [Full Text] [Related]

  • 12. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis.
    Jiang H, Movsesyan V, Fink DW, Fasler M, Whalin M, Katagiri Y, Monshipouri M, Dickens G, Lelkes PI, Guroff G, Lazarovici P.
    J Cell Biochem; 1997 Aug 01; 66(2):229-44. PubMed ID: 9213224
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 14. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains.
    Pérez P, Coll PM, Hempstead BL, Martín-Zanca D, Chao MV.
    Mol Cell Neurosci; 1995 Apr 17; 6(2):97-105. PubMed ID: 7551570
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C, Ultsch MH, Bass SH, de Vos AM.
    Nature; 1999 Sep 09; 401(6749):184-8. PubMed ID: 10490030
    [Abstract] [Full Text] [Related]

  • 16. Neurobiology. trking neurotrophic receptors.
    Ragsdale C, Woodgett J.
    Nature; 1991 Apr 25; 350(6320):660-1. PubMed ID: 1850820
    [No Abstract] [Full Text] [Related]

  • 17. The trk proto-oncogene encodes a receptor for nerve growth factor.
    Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M.
    Cell; 1991 Apr 05; 65(1):189-97. PubMed ID: 1849459
    [Abstract] [Full Text] [Related]

  • 18. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene.
    Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M.
    Nature; 1994 Mar 17; 368(6468):246-9. PubMed ID: 8145823
    [Abstract] [Full Text] [Related]

  • 19. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
    Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM.
    Cell Growth Differ; 1990 Sep 17; 1(9):421-8. PubMed ID: 1963076
    [Abstract] [Full Text] [Related]

  • 20. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.
    Cordon-Cardo C, Tapley P, Jing SQ, Nanduri V, O'Rourke E, Lamballe F, Kovary K, Klein R, Jones KR, Reichardt LF.
    Cell; 1991 Jul 12; 66(1):173-83. PubMed ID: 1649007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.